SAMPRE NUTRITIONS LTD.

Sampre Nutritions Limited has announced that its Board of Directors will convene on November 6, 2026. The primary agenda item for this meeting is the consideration and approval of the unaudited standalone and consolidated financial results for the second quarter, which ended on September 30, 2026, for the financial year 2026-27. This meeting is being held in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Sampre Nutritions Ltd has announced the closure of its trading window for the second quarter ended September 30, 2026. This closure, effective from October 1, 2026, will last until 48 hours after the declaration of the unaudited standalone and consolidated financial results for the period. The company is adhering to SEBI (Prohibition of Insider Trading) Regulations, 2015, and its internal code of conduct. All promoters, directors, designated persons, and their immediate relatives are prohibited from trading in the company's securities during this period. The date for the Board of Directors' meeting to approve these results will be communicated separately.

Sampre Nutritions Ltd announced the allotment of 1,770,710 fully paid-up equity shares at an issue price of INR 42 each, including a premium of INR 37. This preferential allotment, aggregating to INR 7,43,69,820, was made upon conversion of unsecured loans. The shares were allotted to Brahma Gurbani and Meera Gurbani. The Board of Directors approved this allotment during their meeting held on September 25, 2026, following a special resolution passed by the members on December 10, 2025, and in-principle approval from BSE.

Sampre Nutritions Limited has received in-principle approval from the BSE for the issuance and allotment of 1,770,710 equity shares of INR 5 each at a price of not less than INR 42 each. These shares will be issued to the promoter and promoter group on a preferential basis, converting unsecured loans aggregating to INR 7,43,69,820. The company has been advised to strengthen internal controls and obtain undertakings from allottees regarding trading restrictions to ensure compliance with SEBI regulations.

Sampre Nutritions Ltd has informed the stock exchanges about dispatching letters to shareholders holding shares in physical form. These letters contain a QR code providing direct access to the Annual Report for the financial year 2025-26 and the Notice of the 35th Annual General Meeting (AGM). This measure is in compliance with SEBI Listing Regulations for shareholders whose email addresses are not registered. The AGM is scheduled for September 4, 2026. Shareholders are also reminded to update KYC details and consider dematerializing physical shares as per SEBI's recent circular.

Sampre Nutritions Ltd has issued a corrigendum to the notice of its 35th Annual General Meeting (AGM). The corrigendum rectifies a typographical error concerning the date of appointment of the scrutinizer. The company states that this error was purely typographical and did not affect the substance of the AGM notice, proposed resolutions, or the Annual Report. The corrected Annual Report has been dispatched to members and uploaded on the company's website. The 35th AGM is scheduled for September 4, 2026, to be held via Video Conferencing.

Sampre Nutritions Ltd has announced its 35th Annual General Meeting (AGM) scheduled for September 4, 2026, at 11:00 AM IST, to be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has also released its Annual Report for the financial year 2025-26. The intimation for both the annual report and the AGM notice was disseminated on August 10, 2026. The annual report is being circulated electronically to members with registered email addresses and via web link to others. The report includes details on the Board of Directors, statutory committees, key managerial personnel, auditors, bankers, and registrar and share transfer agents.

Sampre Nutritions Ltd has announced its 35th Annual General Meeting (AGM) will be held on Friday, September 4, 2026, at 11:00 AM IST. The meeting will be conducted virtually through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company will also share its Annual Report for the financial year 2025-26 with its members. Key agenda items include adopting the audited financial statements for FY26, reappointing Vishal Ratan Gurbani as Director, and approving a significant revision in his remuneration from ₹18,00,000 to ₹60,00,000 per annum, effective April 1, 2026. The cut-off date for remote e-voting is August 28, 2026, with the e-voting period commencing on September 1 and concluding on September 3, 2026.

Sampre Nutritions Limited has announced a Board of Directors meeting scheduled for August 5, 2026. The primary agenda items include the consideration and approval of the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. Additionally, the board will decide on the date, time, and venue for the 35th Annual General Meeting (AGM) and approve its notice. A significant proposal to increase the annual remuneration of Vishal Gurbani, Whole-Time Director, from INR 18,00,000 to INR 60,00,000, effective April 1, 2026, subject to member approval at the AGM, will also be discussed.

Sampre Nutritions Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI regulations and the company's code of conduct, specifically for the announcement of unaudited standalone and consolidated financial results for the first quarter of the financial year 2026-27, ending on June 30, 2026. The trading window will remain shut from July 1, 2026, until 48 hours after the declaration of these financial results. The exact date of the Board of Directors' meeting to approve these results will be communicated later. Promoters, directors, designated persons, and their immediate relatives are prohibited from trading during this period.